Search
Teva Pharmaceutical Industries Ltd
TEVAAdd to Watchlist
33.210USD
+1.010+3.14%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
38.24BMarket Cap
26.97P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+3.14%
5 Days
+0.91%
1 Month
-2.52%
6 Months
+5.29%
Year to Date
+6.41%
1 Year
+95.70%
Key Figures
32.200Open
33.340High
5.57MVolume
26.97P/E TTM
10.51P/E Dynamic
--Dividend TTM
0.48%Turnover Ratio
32.200Prev. Close
32.120Low
111.20MTurnover
LossP/E Static
4.70P/B
0.00%Div Yield TTM
3.99%ROA
37.34552wk High
0.81Volume Ratio
-1.64BNet Profit
1.16BShares
1.2314EPS TTM
0.84Beta
21.60%ROE
14.99052wk Low
3.79%Amplitude
49.36%Gross Margin
38.24BMarket Cap
-2.98Reward/Risk
1.84%Risk Rate
TradingKey Stock Score of Teva Pharmaceutical Industries Ltd
Currency: USD Updated: 2026-06-23Key Insights
Teva Pharmaceutical Industries Ltd's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 59 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 40.26.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Teva Pharmaceutical Industries Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Teva Pharmaceutical Industries Ltd Highlights
StrengthsRisks
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 26.97, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 725.07M shares, increasing 1.25% quarter-over-quarter.
Held by Francisco Garcia Parames
Star Investor Francisco Garcia Parames holds 3.74M shares of this stock.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
40.263
Target Price
+25.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Teva Pharmaceutical Industries Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Teva Pharmaceutical Industries Ltd Info
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker SymbolTEVA
CompanyTeva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
Websitehttps://www.tevapharm.com/
Related Instruments
+0.54%
+3.37%
+2.07%
+2.98%
+3.54%
+2.60%
+0.66%
+3.33%
+0.14%
-1.44%
+0.32%
+1.53%
+2.59%
-0.36%
+2.58%
0.00%
+0.90%
-5.50%
+2.77%
+2.33%Popular Instruments
72.589
-0.356 (-0.49%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4063.040
-47.710 (-1.16%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62558.270
+117.570 (+0.19%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of Teva Pharmaceutical Industries Ltd (TEVA)?
The current price of Teva Pharmaceutical Industries Ltd (TEVA) is 33.21.
What is the symbol of Teva Pharmaceutical Industries Ltd?
The ticker symbol of Teva Pharmaceutical Industries Ltd is TEVA.
What is the 52-week high of Teva Pharmaceutical Industries Ltd?
The 52-week high of Teva Pharmaceutical Industries Ltd is 37.34.
What is the 52-week low of Teva Pharmaceutical Industries Ltd?
The 52-week low of Teva Pharmaceutical Industries Ltd is 14.99.
What is the market capitalization of Teva Pharmaceutical Industries Ltd?
The market capitalization of Teva Pharmaceutical Industries Ltd is 38.66B.
Is Teva Pharmaceutical Industries Ltd (TEVA) currently rated as Buy, Hold, or Sell?
According to analysts, Teva Pharmaceutical Industries Ltd (TEVA) has an overall rating of Buy, with a price target of 40.26.
What is the Earnings Per Share (EPS TTM) of Teva Pharmaceutical Industries Ltd (TEVA)?
The Earnings Per Share (EPS TTM) of Teva Pharmaceutical Industries Ltd (TEVA) is 1.23.
